Triclabendazole
Triclabendazole is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please sign in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
Triclabendazole is not currently FDA approved for use in the United States.
- Available through the CDC under an investigational drug protocol
- Triclabendazole is included on the WHO Essential Drug List for the management of fascioliasis.
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: October 25, 2016
Citation
* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Triclabendazole
ID - 540674
A1 - Dzintars,Kathryn,PharmD, BCPS
Y1 - 2016/10/25/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540674/all/Triclabendazole
PB - The Johns Hopkins University
DB - Johns Hopkins Guide
DP - Unbound Medicine
ER -